Literature DB >> 18577447

Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).

Jia-You Fang1, Chia-Lang Fang, Chi-Hsien Liu, Yu-Han Su.   

Abstract

Solid lipid nanoparticles (SLN) were developed by using Precirol ATO 5 as the solid core of the particles for topical psoralen delivery. Nanostructured lipid carriers (NLC) consisting of Precirol and squalene, a liquid lipid, were also prepared for comparison. SLN and NLC showed respective mean particle sizes of approximately 300 and 200nm, respectively. Viscosity, polarity, and differential scanning calorimetry (DSC) studies were performed to characterize the physicochemical properties of the SLN and NLC. The viscosity of all nanoparticulate systems exhibited Newtonian behavior except the NLC with Tween 80 and soybean phospholipids as the emulsifiers (NLC-Tw). According to the DSC thermograms, the melting peak of Precirol shifted from 58 to 55 degrees C after incorporating squalene into the solid lipid cores (of NLC), which suggests defects in the crystalline lattice of the lipid cores and smaller particle sizes. Three psoralen derivatives for psoriasis treatments were loaded in SLN and NLC to examine their ability to permeate skin. The permeability of psoralens increased in the order of 8-methoxypsoralen (8-MOP)>5-methoxypsoralen (5-MOP)>4,5,8-trimethylpsoralen (TMP). Enhanced permeation and controlled release of psoralen delivery were both achieved using the NLC. The in vitro permeation results showed that NLC-Tw increased the 8-MOP flux 2.8 times over that of a conventional emulsion. Hyperproliferative or psoriasis-like skin produced by repeated strippings in the dorsal skin of nude mouse was also used as a permeation barrier. The results showed that the entrapment of 8-MOP in nanoparticulate systems could minimize the permeation differentiation between normal and hyperproliferative skin compared to the free drug in an aqueous control.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18577447     DOI: 10.1016/j.ejpb.2008.05.008

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  56 in total

1.  Dermal microdialysis technique to evaluate the trafficking of surface-modified lipid nanoparticles upon topical application.

Authors:  Pinaki R Desai; Punit P Shah; Ram R Patlolla; Mandip Singh
Journal:  Pharm Res       Date:  2012-05-30       Impact factor: 4.200

2.  Impact of different vehicles for laser-assisted drug permeation via skin: full-surface versus fractional ablation.

Authors:  Woan-Ruoh Lee; Shing-Chuan Shen; Ibrahim A Aljuffali; Yi-Ching Li; Jia-You Fang
Journal:  Pharm Res       Date:  2014-02       Impact factor: 4.200

3.  Risk assessment of excess drug and sunscreen absorption via skin with ablative fractional laser resurfacing : optimization of the applied dose for postoperative care.

Authors:  Wei-Yu Chen; Chia-Lang Fang; Saleh A Al-Suwayeh; Hung-Hsu Yang; Yi-Ching Li; Jia-You Fang
Journal:  Lasers Med Sci       Date:  2013-01-06       Impact factor: 3.161

4.  Process optimization and photostability of silymarin nanostructured lipid carriers: effect on UV-irradiated rat skin and SK-MEL 2 cell line.

Authors:  Pooja Singh; Mahendra Singh; Jovita Kanoujia; Malti Arya; Shailendra K Saraf; Shubhini A Saraf
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

5.  Engineering solid lipid nanoparticles for improved drug delivery: promises and challenges of translational research.

Authors:  Dinesh Kumar Mishra; Vinod Dhote; Punit Bhatnagar; Pradyumna Kumar Mishra
Journal:  Drug Deliv Transl Res       Date:  2012-08       Impact factor: 4.617

6.  Skin targeting of resveratrol utilizing solid lipid nanoparticle-engrossed gel for chemically induced irritant contact dermatitis.

Authors:  S N Shrotriya; N S Ranpise; B V Vidhate
Journal:  Drug Deliv Transl Res       Date:  2017-02       Impact factor: 4.617

Review 7.  The Impact of Variables on Particle Size of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers; A Comparative Literature Review.

Authors:  Leila Azhar Shekoufeh Bahari; Hamed Hamishehkar
Journal:  Adv Pharm Bull       Date:  2016-06-30

8.  Overcoming clofazimine intrinsic toxicity: statistical modelling and characterization of solid lipid nanoparticles.

Authors:  Luíse L Chaves; Sofia Lima; Alexandre C C Vieira; Domingos Ferreira; Bruno Sarmento; Salette Reis
Journal:  J R Soc Interface       Date:  2018-02       Impact factor: 4.118

9.  Fetuin-A/albumin-mineral complexes resembling serum calcium granules and putative nanobacteria: demonstration of a dual inhibition-seeding concept.

Authors:  Cheng-Yeu Wu; Jan Martel; David Young; John D Young
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

10.  Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery.

Authors:  Yin-Ku Lin; Zih-Rou Huang; Rou-Zi Zhuo; Jia-You Fang
Journal:  Int J Nanomedicine       Date:  2010-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.